Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 896 of 6351
-
Could gentle fascia release restore shoulder mobility after breast cancer surgery?
Symptom relief CompletedIn breast cancer patients, limitation of shoulder joint movement occurs following mastectomy surgery. Studies have reported that damage to the fascia on the pectoralis major muscle during mastectomy surgery contributes to the development of the limitation. The aim of this study i…
Sponsor: Istanbul Medeniyet University • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
New MRI method could revolutionize prostate cancer screening for High-Risk men
Diagnosis Recruiting nowTo determine whether using bpMRI in subjects who are at high risk of developing prostate cancer in conjunction with PSA will improve prostate cancer screening protocols.
Sponsor: Northwell Health • Aim: Diagnosis
Last updated Jun 27, 2026 07:59 UTC
-
Immune cell therapy shows promise for tough leukemia cases
Disease control Stopped earlyThis is an open-label, phase II study designed to evaluate the efficacy and effectiveness of TCB008 in patients with Acute Myeloid Leukemia (AML), or Myelodysplastic Syndromes (MDS)/AML, with either refractory or relapsed disease. Five patients will be recruited for an initial s…
Phase 2 • Sponsor: TC Biopharm • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New antibody-chemo combo shows promise for mesothelioma
Disease control CompletedPM8002 is a bispecific antibody targeting PD-L1 and VEGF. This study will evaluate the efficacy and safety of PM8002 in combination with pemetrexed and platinum as first line treatment for MPM.
Phase 2 • Sponsor: Biotheus Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Sound waves may help cancer drugs reach the brain
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and efficacy of targeted blood brain barrier opening with Exablate Model 4000 Type 2.0/2.1 for the treatment of NSCLC brain metastases in patients who are undergoing planned FDA approved, on-label systemic therapy utilizing immu…
Phase 3 • Sponsor: InSightec • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Immune cells take on brain cancer in first human test
Disease control OngoingThis study is a open-label, dose-escalation trial to explore the safety, tolerability and pharmacokinetic/pharmacodynamics characteristics of Human CD19-CD22 Targeted T Cells by intravenous and intrathecal administration, and to preliminarily observe the efficacy of the trial dru…
Early phase 1 • Sponsor: Hrain Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Ketamine boost keeps bipolar depression at bay in small trial
Disease control CompletedGrowing evidence has supported rapid and robust antidepressant effects with subanesthetic doses of intravenous (IV) ketamine for treatment resistant depression (TRD). However, no completed or ongoing RCTs have evaluated the effects of repeated doses of IV ketamine for a homogenou…
Phase 2 • Sponsor: Joshua Rosenblat • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New drug cocktail aims to boost myeloma remission
Disease control OngoingThis phase I/II trial studies the side effects and best dose of iberdomide and how well it works in combination with daratumumab, bortezomib, and dexamethasone in treating patients with newly diagnosed multiple myeloma. Immunotherapy with iberdomide, may induce changes in body's …
Phase 1/2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug cocktail aims to prevent rare melanoma recurrence
Disease control OngoingThis phase II trial tests whether nivolumab in combination with cabozantinib works in patients with mucosal melanoma. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cell…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New study aims to stop teen suicide by finding what works best
Knowledge-focused Recruiting nowTo inform the effective management of adolescent suicide risk by evaluating promising treatments and developing the evidence-base for interventions that are well suited for widespread adoption, sustained quality, and impact.
Sponsor: Seattle Children's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
New gel may stop uterine scars after surgery
Disease control CompletedThis study is to determine whether intrauterine instillation of Juveena hydrogel following adhesiogenic hysteroscopic procedures (TCGP + Juveena) can safely and effectively reduce the incidence and severity of intrauterine adhesions (IUA) compared to TCGP alone.
Phase 3 • Sponsor: Rejoni Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a new strategy break the cycle of HIV care dropout?
Knowledge-focused Completed1.0 Introduction The scale-up of human immunodeficiency virus (HIV) treatment services has expanded rapidly in Zambia, facilitated by evolution of the HIV response from centralized services to decentralized care and now towards differentiated service delivery models. Nevertheles…
Sponsor: Centre for Infectious Disease Research in Zambia • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
New Natural-Material heart valve could fix tricuspid trouble
Disease control Recruiting nowThe goal of this pivotal study is to demonstrate the safety and performance of the Cor TRICUSPID ECM (extracellular matrix) Valve (or Cor PEDIATRIC Tricuspid ECM Valve) for the surgical management of tricuspid valve disease and dysfunction in adult and pediatric patients. The mai…
Sponsor: Corvivo Cardiovascular, Inc. • Aim: Disease control
Last updated Jun 26, 2026 12:37 UTC
-
New drug could tame lupus kidney flares
Disease control Recruiting nowThe overall purpose of this two-part study is to evaluate the efficacy, safety and tolerability of iptacopan (LNP023) in addition to standard of care treatment.
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New migraine prevention pill shows promise in japanese trial
Disease control CompletedThis study is being conducted to evaluate the efficacy, safety, and tolerability of rimegepant in Japanese subjects for the prevention of migraine.
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New trial tailors anal cancer treatment for people with HIV
Disease control OngoingThis phase II trial studies the side effects of chemotherapy and intensity modulated radiation therapy in treating patients with low-risk HIV-associated anal cancer, and nivolumab after standard of care chemotherapy and radiation therapy in treating patients with high-risk HIV-as…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Outpatient CAR T-Cell therapy shows promise for tough lymphoma
Disease control CompletedThe goal of this clinical study is to learn more about the study drug, axicabtagene ciloleucel, in participants with relapsed or refractory large B-cell lymphoma (LBCL) in the outpatient setting.
Phase 2 • Sponsor: Kite, A Gilead Company • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Ultrasound-Guided ventilation aims to cut ARDS deaths
Disease control Recruiting nowRationale Acute respiratory distress syndrome (ARDS) is a frequent cause of hypoxemic respiratory failure with a mortality rate of approximately 30%. The identification of ARDS phenotypes, based on focal or non-focal lung morphology, can be helpful to better target mechanical ven…
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Can community hospitals in zambia master severe disease care?
Disease control Recruiting nowCognizant of the prevalence of complicated non communicable diseases (NCD) and the attendant capacity problems faced by the health workers in primary care settings, we propose to adapt and pilot the Package of Essential Non-communicable Diseases (PEN) Plus intervention using the …
Sponsor: Centre for Infectious Disease Research in Zambia • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can getting kids moving sooner in the ICU shorten their time on a ventilator?
Disease control Recruiting nowWhile mortality in U.S. pediatric intensive care units (PICUs) is improving, surviving children frequently develop persistent physical, cognitive, and psychological impairments. Over half of critically ill children experience potentially preventable PICU-acquired morbidities, wit…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC